4.7 Article

Tau plasma levels in subjective cognitive decline: Results from the DELCODE study

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease

Rachel F. Buckley et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2016)

Article Clinical Neurology

Plasma tau in Alzheimer disease

Niklas Mattsson et al.

NEUROLOGY (2016)

Article Clinical Neurology

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

Shorena Janelidze et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)

Article Biochemistry & Molecular Biology

Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer's Disease

Kai-Yuan Tzen et al.

ACS CHEMICAL NEUROSCIENCE (2014)

Article Clinical Neurology

AD dementia risk in late MCI, in early MCI, and in subjective memory impairment

Frank Jessen et al.

ALZHEIMERS & DEMENTIA (2014)

Article Clinical Neurology

The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?

Flora H. Duits et al.

ALZHEIMERS & DEMENTIA (2014)

Letter Clinical Neurology

Plasma tau levels in Alzheimer's disease

Henrik Zetterberg et al.

ALZHEIMERS RESEARCH & THERAPY (2013)

Article Clinical Neurology

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

Michelle T. Fodero-Tavoletti et al.

BRAIN (2011)

Article Biotechnology & Applied Microbiology

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

David M. Rissin et al.

NATURE BIOTECHNOLOGY (2010)

Article Clinical Neurology

Subjective memory complaints, education, and risk of Alzheimer's disease

Marieke van Oijen et al.

ALZHEIMERS & DEMENTIA (2007)